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We describe a case of intermediate leptospirosis resulting 
from Leptospira licerasiae infection in a traveler returning 
to Japan from Brazil. Intermediate leptospirosis should be 
included in the differential diagnosis for travelers with fever 
returning from South America. This case highlights the need 
for strategies that detect pathogenic and intermediate Lep-
tospira species.
Leptospirosis, caused by spirochetes of the genus Lepto-spira, is a neglected zoonotic disease found in tropical 
and subtropical regions. Leptospira species are classified 
into 3 groups on the basis of 16S rRNA gene sequences: 
pathogenic, intermediate, and saprophytic groups. Al-
though Leptospira species from the pathogenic group are 
considered to be the main cause of leptospirosis, Chiriboga 
et al. reported that most cases of leptospirosis in Ecuador 
were caused by intermediate species (1). We describe a 
case of leptospirosis caused by L. licerasiae, an intermedi-
ate species, in a traveler returning to Japan from Brazil.
In late November 2015, a previously healthy 40-year-
old Japanese man sought treatment at the National Center for 
Global Health and Medicine (Tokyo, Japan) with a high fever 
and shaking chills. He had recently spent 15 days in Co-
rumbá, Brazil, where he worked as part of a camera crew 
in mid-November 2015. He used insect repellent during his 
trip but had been bitten by mosquitoes many times while 
walking and swimming in waist-deep water in the Brazilian 
wetlands. His symptoms began 6 days after his return from 
Brazil and included high fever, chills, arthralgia and myal-
gia in his elbow and knee joints, and burning skin pain over 
the his whole body for the 24 hours before he sought treat-
ment. At the time of his first visit to this clinic, he reported 
new onset retroorbital pain and shaking chills.
On examination, his body temperature was 39.5°C and 
his pulse rate was relatively low (87 beats/min). He had mild 
congested bulbar conjunctivae, localized urticaria on his 
trunk, and many small, old injury scars on both of his legs 
(online Technical Appendix Figure 1, https://wwwnc.cdc.
gov/EID/article/22/3/16-1262-Techapp1.pdf). Results of rap-
id antigen detection tests and Giemsa stains of blood smears 
for Plasmodium spp. were negative for 3 consecutive days. 
Results of laboratory tests were negative, including IgM, IgG, 
and NS-1 antigen tests against dengue virus; HIV screening; 
rapid antigen detection test against influenza virus; and blood 
and urine cultures. Moreover, PCR results for Leptospira and 
for dengue, chikungunya, and Zika viruses were negative.
Treatment with ceftriaxone (2 g 1×/d) was initiated 1 
day after hospital admission. Four hours after infusion be-
gan, the patient’s fever rose to 40°C, which was considered 
a Jarisch-Herxheimer reaction. Fever resolved the next 
day. Laboratory test results showed elevated total biliru-
bin (2.3 mg/dL [reference range 0.3–1.2mg/dL]), aspartate 
aminotransferase (62 U/L [13–33 U/L]), alanine amino-
transferase (73 U/L [8–42 U/L]), lactic acid dehydrogenase 
(456 U/L [119–229]), and C-reactive protein (13.6 mg/
dL [0–0.3 mg/dL]), but these values quickly returned to 
within reference ranges. Three days after ceftriaxone treat-
ment began, all symptoms had resolved, and the patient 
was discharged from the hospital with a prescription for 
doxycycline (100 mg 2×/d).
At the time of discharge, 3 days after the blood cul-
ture was set up, spirochetes were observed in Korthof and 
EMJH media. Nucleotide sequencing of the 16S rRNA gene 
of the isolate, NIID18 (Japan National Bioresource of Bac-
terial Pathogens no. 18467, http://pathogenic.lab.nig.ac.jp/) 









y/sex Location Occupation Symptoms Therapy Prognosis Ref. 
VAR10 31/F Varillal, 
Peru 
Food vendor 2-d history of fever, malaise, chills, headache, 
dizziness 
Antipyretics Resolved 5 d 
later 
(7) 





5-d history of fever, malaise, chills, headache, 
dizziness, leg pain and weakness, abdominal 
pain, anorexia, nausea, vomiting 
None Resolved† (7) 
NIID18 40/M Corumbá, 
Brazil 
Camera crew 1-d history of fever, shaking chills, retroorbital 
pain, arthralgia and myalgia in elbow and knee 
joints, burning skin pain over the whole body, 
congested bulbar conjunctivae 
CTRX 2 g/d 
for 4 d, then 
DOX 100 mg 
2/d for 3 d 
Resolved 





*CTRX, ceftriaxone; DOX, doxycycline; ref., reference. 
†The day when the symptoms resolved was not described in the report. 
 
(online Technical Appendix Figure 2), revealed it to 
be L. licerasiae: the sequence (GenBank accession no. 
LC164227) had 99.3% identity (1,339/1,348 bp) with VAR 
010 (GenBank accession no. EF612284), the type strain of 
L. licerasiae. The partial flaB sequence of the NIID18 iso-
late (GenBank accession no. LC164228) also showed the 
highest similarity with VAR 010 (96.6%, GenBank acces-
sion no. LC005426). NIID18 did not react with a panel of 
antisera for 18 serovars (2). An increase in antibody titers 
in paired serum samples was observed against the isolate 
(reciprocal titers 50 and 200 in acute- and convalescent-
phase samples, respectively), according to microscopic 
agglutination test (3). After receiving antimicrobial drug 
therapy for 7 days, the patient had completely recovered.
The intermediate Leptospira group comprises 5 spe-
cies: L. licerasiae, L. wolffii, L. fainei, L. broomii, and L. 
inadai. Although this species group has been detected in 
environmental soil and water samples from the Southeast 
Asia (4–6), human cases involving returned travelers have 
not been well-documented previously (1,7–10). To our 
knowledge, only 2 cases of L. licerasiae isolation from 
a human host have been reported; such isolations were 
first reported in Peru in 2008 (7) (Table), although many 
serum samples from febrile patients in the Peruvian Ama-
zon have reacted with an L. licerasiae isolate. Members 
of Rattus species are considered major reservoir hosts (7).
We were unable to detect Leptospira DNA in the case-
patient’s blood using flaB-nested PCR because this method 
is specific to species in the pathogenic group. The patient 
received a diagnosis of leptospirosis after L. licerasiae 
was isolated from a blood culture. Therefore, PCR target-
ing conserved genes among genus Leptospira, such as 16S 
rRNA, is more suitable not only for clinical situations but 
also for epidemiologic studies.
This case highlights the need for including leptospi-
rosis caused by intermediate group species in the differen-
tial diagnosis for patients with fever who have recently re-
turned from South America. In addition, we emphasize the 
utility of genes such as 16S rRNA for detecting pathogenic 
and intermediate Leptospira groups.
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